The COVID-19 Vaccine and Global Mobility Programs
Recent approvals for COVID-19 vaccines have led to questions about how or if individuals on international assignments will receive vaccination support from their employers.
AIRINC conducted a pulse survey to understand what support, if any, companies plan to extend to employees on assignment. Survey results show that most companies are either unsure what they will do (45% of participants) or plan not to extend special support to employees beyond what is already provided via medical insurance and locally available healthcare (45% of participants).
AIRINC continues to monitor how companies approach the challenges posed by COVID-19. If you are looking for additional insights to help make informed program decisions, we encourage you to reach out to your AIRINC team today.
Listen | Partner | Deliver. For over 60 years, AIRINC has helped clients with the right data, cutting-edge technology, and thought-leading advice needed to effectively deploy talent worldwide. Our industry expertise, solutions, and service enable us to effectively partner with clients to navigate the complexity of today’s global mobility programs. As the market continues to evolve, AIRINC seeks innovative ways to help clients address new workforce globalization challenges, including mobility program assessment metrics and cross-border talent mobility strategy. Our approach is designed with your success in mind. With an understanding of your goals and objectives, we ensure you achieve them. Headquartered in Cambridge, MA, USA, AIRINC has full-service offices in Brussels, London, and Hong Kong. Learn more by clicking here.